Overview

Selegiline Patch for Treatment of Nicotine Dependence

Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
Relapse to smoking is a common problem affecting smokers who seek treatment. The purpose of this study is examine whether selegiline, given in the form of a skin patch, is effective in stopping smoking.
Phase:
Phase 2
Details
Lead Sponsor:
Stanford University
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Nicotine
Selegiline